noninvasive cancer. the to efficacious seen IG-SRT highly for modality as very their treat and And importance XXXX. Kim, positive everyone. Thank you, recognizes practices in non-melanoma and has dermatology their to excellent delighted good afternoon, some of community skin as patients the QX report and I'm Sensus Healthcare to results momentum.
to value introduced expose continue choice in market Dermatologists are our the our program. formally our to agreement dermatology new as is in spread options, acquisition Fair we the The throughout. to community the momentum and gaining benefiting proven deal AAD March, fair begins Agreement complements lease fair as Deal from which at including word now details a
Our than compared first comparable very, results good very revenues XXXX the we quarter. more financial with were quarter as tripled
addition, that environment, reflects to last profit compared macroeconomic year's adjustments the especially In loss. with a recorded our net we substantial customers'
systems compared year when plans. inflation quarter with pronounced XX businesses, spending during had shipped and macroeconomic on We uncertainty the a our ago XX and effect confidence customers'
dermatology. persist, seeing shift determined headwinds medical by macroeconomic a Although toward a aesthetic the we are dermatology platform dermatologists versus
Miami medical we all we enjoyed X As In them. we shows February, every year, of trade the important year's XX,XXX Meeting, we attended American do at this of attended very than Then South our Agreement traffic booth the Winter attend where the Clinical new the time at and U.S. largest in event. we with Fair Academy more Beach annual excellent Dermatology gathering Annual in Deal dermatologists of Symposium. in March, launched the and this to personnel
the patent effective. Fair value with gain radiotherapy and only dermatology second a combined to holds sells proven manufactures Sensus proposition the with superficial to award-winning for none. model that's deeper image-guided, IG-SRT Sensus Under is service and new Agreement, under access an SRT ultrasound, Deal and FDA-cleared system which more technology a economic offices
conference optimistic our attendees expectations. among response exceeded The most
an the now offering sales generated portfolio leads products. delivering best customers record-high are simply, also Quite while SRT economic a we best of agreement the choice. We number for our under of technology
fair Fair our XX.X%. to market model the This non-melanoma of formula new up lease noninvasively Our recently, to Deal cure to proven our value skin with simplest and, has long-standing capital cancer more complements sales expand Agreement highest the equipment market. technology and model rates treat our
with pipeline Fair growing we the leads assembled Deal service Sensus. get unmatched Agreement, a and SRT expect regarded and the the know that best customer to entered in highly delighted we've are under industry, progresses. value they have quality, the and already and Our dermatologists year compelling Vision established and most of contracts proposition will corporate the several to into brands We're convert as well product
that for more model addresses the image high-resolution, all our provides is leads laws availability of been can abiding agreement HIPAA-compliant by user-friendly review, improved includes to Agreement recurring economics their the a deploy a the of Vision, best our see work and with impact The Note us making with and To market world-class the recurring business, the and revenue it for of lesion capabilities Deal ultrasound this a compelling the to and that revenue a each also both Fair need option The clinical lesion see-and-treat the planning which preparing sure Sentinel a our the in regulations. economic actually guided applicable customers' the that SRT-XXX treatment. now believe treatment make combination software, and possible. ensuring we than model image-guided which and for resolution outcomes value capability, technology what and of ultrasound model. the facilitates proposition that areas we technology other to because provides after physician technology, the capital on We've the today. is great customers the of carefully base year, were
customers the the practice. dermatology Deal first enhance CureRays oversight quarter, and with of engaged and efficiency Fair utmost to provide the Agreement supervision we during and effectiveness To facilitate the
for CureRays radiotherapy, Sensus superficial addition, diseases. new will research inflammatory In including indications
patented system included seamless ultrasound, individual made claims. the a by possible that's Vision. launching shows, planning treatment radiation we our at describes the device essentially to addition therapy trade a newly operation. In also fusing these capabilities patent the state-of-the-art technology high-frequency XX The Deal Agreement covering the SRT-XXX showcased in technology with Fair This embedded permitting
of as highlight our potential his year ordered a Between end assembled will so of so the the prepared satisfy interest technology the pipeline new to remarks. anticipation by new demand, sales more much we that and in offering, in significant this customers, and have we've inventory Javier
market, this primary a our engage to mainly with is channel. dermatology oncology continue we which radiation market, is While hospital-based
continue sales this reminder, generate a has interest. As to increased we market a as cycle longer
our TransDermal Infusion, Turning FDA XXXX. recall of with quarter product, the our filed that we fourth XXX application in now TDI the U.S. to or
We will optimistic deal the allow plasma, This in interest awaiting TDI progress. restoration applied and experience. be coming the from a still for as product PRP, be this to in or are will, shows are to of great and half pain-free it example, We've platelet-rich a in agency a response works of second it system the in year. generated our trade scalp
overactive posters on sweat In presented application already its been hyperhidrosis addition, glands. have for or
includes capabilities. IT Solution system Our Sentinel TransDermal
turn remarks, you over who business. Michael call a to our Sardano, on and General those the update I'll Counsel, Michael? international With brief our President will give
